{"id":"https://openalex.org/W7124747809","doi":"https://doi.org/10.30809/phe.4.2025.3","title":"Pharmacoeconomic evaluation of the treatment of psoriatic arthritis and ankylosing spondylitis with biological medicines and targeted small molecule medicines at the regional level","display_name":"Pharmacoeconomic evaluation of the treatment of psoriatic arthritis and ankylosing spondylitis with biological medicines and targeted small molecule medicines at the regional level","publication_year":2025,"publication_date":"2025-12-15","ids":{"openalex":"https://openalex.org/W7124747809","doi":"https://doi.org/10.30809/phe.4.2025.3"},"language":"en","primary_location":{"id":"doi:10.30809/phe.4.2025.3","doi":"https://doi.org/10.30809/phe.4.2025.3","is_oa":true,"landing_page_url":"https://doi.org/10.30809/phe.4.2025.3","pdf_url":"https://pharmacoeconom.com/netcat_files/401/620/3_14.pdf","source":{"id":"https://openalex.org/S4210180659","display_name":"Pharmacoeconomics theory and practice","issn_l":"2312-2862","issn":["2312-2862"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["russia-white-list-2"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacoeconomics: theory and practice","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://pharmacoeconom.com/netcat_files/401/620/3_14.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044907261","display_name":"Roza Ismailovna Yagudina","orcid":"https://orcid.org/0000-0002-9080-332X","observed_orcids":["https://orcid.org/0000-0002-9080-332X"]},"institutions":[{"id":"https://openalex.org/I17877952","display_name":"Sechenov University","ror":"https://ror.org/02yqqv993","country_code":"RU","type":"education","lineage":["https://openalex.org/I17877952"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"R. I. Yagudina","raw_affiliation_strings":["Sechenov University . Head of Department of organization of medical provision and pharmacoeconomics"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sechenov University . Head of Department of organization of medical provision and pharmacoeconomics","institution_ids":["https://openalex.org/I17877952"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5123315772","display_name":"A. Yu. Kulikov","orcid":"https://orcid.org/0000-0002-5259-1266","observed_orcids":["https://orcid.org/0000-0002-5259-1266"]},"institutions":[{"id":"https://openalex.org/I17877952","display_name":"Sechenov University","ror":"https://ror.org/02yqqv993","country_code":"RU","type":"education","lineage":["https://openalex.org/I17877952"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"A. Yu. Kulikov","raw_affiliation_strings":["Sechenov University . P rof . of Department of organization of medical provision and pharmacoeconomics"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sechenov University . P rof . of Department of organization of medical provision and pharmacoeconomics","institution_ids":["https://openalex.org/I17877952"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050669271","display_name":"V.G. Serpik","orcid":"https://orcid.org/0000-0002-6896-2842","observed_orcids":["https://orcid.org/0000-0002-6896-2842"]},"institutions":[{"id":"https://openalex.org/I17877952","display_name":"Sechenov University","ror":"https://ror.org/02yqqv993","country_code":"RU","type":"education","lineage":["https://openalex.org/I17877952"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"V. G. Serpik","raw_affiliation_strings":["Sechenov University. Assoc. prof . of Department of organization of medical provision"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sechenov University. Assoc. prof . of Department of organization of medical provision","institution_ids":["https://openalex.org/I17877952"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075646239","display_name":"I.A. Vinogradova","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"I. B. Vinogradova","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035535136","display_name":"L. V. Solodovnikova","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096547","display_name":"Ulyanovsk Regional Clinical Hospital","ror":"https://ror.org/00zsz8144","country_code":"RU","type":"healthcare","lineage":["https://openalex.org/I4210096547"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"L. V. Solodovnikova","raw_affiliation_strings":["State Healthcare","State Healthcare Institution Ulyanovsk Regional Clinical Hospital . Ulyanovsk , Russia Head of Rheumatology center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"State Healthcare","institution_ids":[]},{"raw_affiliation_string":"State Healthcare Institution Ulyanovsk Regional Clinical Hospital . Ulyanovsk , Russia Head of Rheumatology center","institution_ids":["https://openalex.org/I4210096547"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034524656","display_name":"L. V. Ivanova","orcid":"https://orcid.org/0000-0003-0411-6118","observed_orcids":["https://orcid.org/0000-0003-0411-6118"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. V. Ivanova","raw_affiliation_strings":["Udmurt Republic , Izhevsk , Russia Head of the Rheumatology Department"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Udmurt Republic , Izhevsk , Russia Head of the Rheumatology Department","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5123308101","display_name":"N. V. Yurchenko","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405280478","display_name":"Government of the Khanty-Mansiysk Autonomous Okrug \u2013 Ugra","ror":"https://ror.org/02zzvvd41","country_code":"RU","type":"government","lineage":["https://openalex.org/I4405280478"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"N. V. Yurchenko","raw_affiliation_strings":["State Institution of the Khanty-Mansi Autonomous Okrug -Yugra \"Center for Drug Monitoring\" , Surgut , Russia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"State Institution of the Khanty-Mansi Autonomous Okrug -Yugra \"Center for Drug Monitoring\" , Surgut , Russia","institution_ids":["https://openalex.org/I4405280478"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5123321194","display_name":"O. B. Nesmeyanova","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"O. B. Nesmeyanova","raw_affiliation_strings":["Chelyabinsk Regional Clinical Hospital , Chelyabinsk , Russia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chelyabinsk Regional Clinical Hospital , Chelyabinsk , Russia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5123296350","display_name":"Iu. Yu. Grabovetskaya","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Iu. Yu. Grabovetskaya","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5123353583","display_name":"O. N. Odnoshivkina","orcid":"https://orcid.org/0009-0003-6019-1005","observed_orcids":["https://orcid.org/0009-0003-6019-1005"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"O. N. Odnoshivkina","raw_affiliation_strings":["Kirov Regional Clinical Hospital , Kirov , Russia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kirov Regional Clinical Hospital , Kirov , Russia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5123302626","display_name":"A. A. Vasilenko","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. A. Vasilenko","raw_affiliation_strings":["Novgorod Regional Clinical Hospital , Veliky Novgorod , Russia Head of the Rheumatology Department"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novgorod Regional Clinical Hospital , Veliky Novgorod , Russia Head of the Rheumatology Department","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5096677463","display_name":"G. F. Fatkhullina","orcid":"https://orcid.org/0009-0006-0991-533X","observed_orcids":["https://orcid.org/0009-0006-0991-533X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G. F Fatkhullina","raw_affiliation_strings":["Republican Clinical Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Republican Clinical Hospital","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091373973","display_name":"Svetlana P. Yakupova","orcid":"https://orcid.org/0000-0002-8590-4839","observed_orcids":["https://orcid.org/0000-0002-8590-4839"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. P. Yakupova","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5008384446","display_name":"\u0422. \u0412. \u041a\u0440\u043e\u043f\u043e\u0442\u0438\u043d\u0430","orcid":"https://orcid.org/0000-0002-0689-8646","observed_orcids":["https://orcid.org/0000-0002-0689-8646"]},"institutions":[{"id":"https://openalex.org/I4210131022","display_name":"Budgetary Healthcare Institution of Omsk Region Regional Clinical Hospital","ror":"https://ror.org/02yxqm243","country_code":"RU","type":"healthcare","lineage":["https://openalex.org/I4210131022"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"T. V. Kropotina","raw_affiliation_strings":["Omsk Region State Healthcare Institution \"Regional Clinical Hospital , \" Omsk , Russia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Omsk Region State Healthcare Institution \"Regional Clinical Hospital , \" Omsk , Russia","institution_ids":["https://openalex.org/I4210131022"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"13","issue":"4","first_page":"19","last_page":"36"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/psoriatic-arthritis","display_name":"psoriatic arthritis","score":0.9980000257492065},{"id":"https://openalex.org/keywords/ankylosing-spondylitis","display_name":"ankylosing spondylitis","score":1.0},{"id":"https://openalex.org/keywords/biological-medicines","display_name":"biological medicines","score":0.7889999747276306},{"id":"https://openalex.org/keywords/small-molecule-targeted-therapy","display_name":"small-molecule targeted therapy","score":0.7699999809265137},{"id":"https://openalex.org/keywords/secukinumab","display_name":"secukinumab","score":0.8669999837875366},{"id":"https://openalex.org/keywords/il-17-inhibitors","display_name":"IL-17 inhibitors","score":0.9419999718666077},{"id":"https://openalex.org/keywords/constituent-entities-of-the-russian-federation","display_name":"constituent entities of the Russian Federation","score":0.5899999737739563}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8252999782562256},{"id":"https://openalex.org/C2776260265","wikidata":"https://www.wikidata.org/wiki/Q511097","display_name":"Psoriatic arthritis","level":3,"score":0.7935000061988831},{"id":"https://openalex.org/C59491497","wikidata":"https://www.wikidata.org/wiki/Q864715","display_name":"Biosimilar","level":2,"score":0.6912999749183655},{"id":"https://openalex.org/C2779703844","wikidata":"https://www.wikidata.org/wiki/Q760125","display_name":"Reimbursement","level":3,"score":0.6496000289916992},{"id":"https://openalex.org/C2777402515","wikidata":"https://www.wikidata.org/wiki/Q52849","display_name":"Ankylosing spondylitis","level":2,"score":0.5164999961853027},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4253999888896942},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.38029998540878296},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.37689998745918274},{"id":"https://openalex.org/C110121322","wikidata":"https://www.wikidata.org/wiki/Q865811","display_name":"Distribution (mathematics)","level":2,"score":0.35089999437332153},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.33820000290870667},{"id":"https://openalex.org/C2908564923","wikidata":"https://www.wikidata.org/wiki/Q810254","display_name":"Antirheumatic drugs","level":4,"score":0.33410000801086426},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.32749998569488525},{"id":"https://openalex.org/C2908701176","wikidata":"https://www.wikidata.org/wiki/Q679692","display_name":"Biological drugs","level":3,"score":0.3172000050544739},{"id":"https://openalex.org/C2910157418","wikidata":"https://www.wikidata.org/wiki/Q7089373","display_name":"Homoharringtonine","level":3,"score":0.3124000132083893},{"id":"https://openalex.org/C2778886723","wikidata":"https://www.wikidata.org/wiki/Q3530324","display_name":"Tofacitinib","level":3,"score":0.3041999936103821},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.2888999879360199},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.26660001277923584},{"id":"https://openalex.org/C2777138892","wikidata":"https://www.wikidata.org/wiki/Q415264","display_name":"Infliximab","level":3,"score":0.26019999384880066},{"id":"https://openalex.org/C3020580240","wikidata":"https://www.wikidata.org/wiki/Q663272","display_name":"Expert opinion","level":2,"score":0.2533000111579895},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.2529999911785126}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.30809/phe.4.2025.3","doi":"https://doi.org/10.30809/phe.4.2025.3","is_oa":true,"landing_page_url":"https://doi.org/10.30809/phe.4.2025.3","pdf_url":"https://pharmacoeconom.com/netcat_files/401/620/3_14.pdf","source":{"id":"https://openalex.org/S4210180659","display_name":"Pharmacoeconomics theory and practice","issn_l":"2312-2862","issn":["2312-2862"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["russia-white-list-2"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacoeconomics: theory and practice","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.30809/phe.4.2025.3","doi":"https://doi.org/10.30809/phe.4.2025.3","is_oa":true,"landing_page_url":"https://doi.org/10.30809/phe.4.2025.3","pdf_url":"https://pharmacoeconom.com/netcat_files/401/620/3_14.pdf","source":{"id":"https://openalex.org/S4210180659","display_name":"Pharmacoeconomics theory and practice","issn_l":"2312-2862","issn":["2312-2862"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["russia-white-list-2"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacoeconomics: theory and practice","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8371999859809875,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7124747809.pdf","grobid_xml":"https://content.openalex.org/works/W7124747809.grobid-xml"},"referenced_works_count":11,"referenced_works":["https://openalex.org/W2607838391","https://openalex.org/W2609891954","https://openalex.org/W2892263842","https://openalex.org/W2973684671","https://openalex.org/W2979709352","https://openalex.org/W3117964443","https://openalex.org/W3131693459","https://openalex.org/W3180838433","https://openalex.org/W4291965948","https://openalex.org/W4366368766","https://openalex.org/W4376873015"],"related_works":["https://openalex.org/W2892263842","https://openalex.org/W3018193220","https://openalex.org/W6929499619","https://openalex.org/W2403778732","https://openalex.org/W4206299241","https://openalex.org/W2996062065","https://openalex.org/W3033947927","https://openalex.org/W7126198590","https://openalex.org/W4246427494","https://openalex.org/W4306946693"],"abstract_inverted_index":{"The":[0,302],"wide":[1],"range":[2],"of":[3,20,33,38,92,97,112,138,183,203,210,227,231,239,245,252,283,298,306,319,351],"medications":[4,42,55,60,98],"complementing":[5],"standard":[6],"therapy":[7,260],"for":[8,25,71,114,155,177,186,270,288,338,342],"psoriatic":[9],"arthritis":[10],"(PsA)":[11],"and":[12,56,67,83,95,110,119,142,160,165,190,214,219,256,261,291,312,326,340],"ankylosing":[13],"spondylitis":[14],"(AS),":[15],"coupled":[16],"with":[17,140,158,188,212,254,310],"the":[18,51,68,90,93,104,108,136,181,204,208,228,246,250,267,271,279,299,320,347,352],"lack":[19],"a":[21,36,124,175,193],"strict":[22],"prescribed":[23],"sequence":[24],"their":[26,47,73],"administration":[27],"that":[28],"would":[29],"establish":[30],"conventional":[31],"lines":[32],"therapy,":[34],"predetermines":[35],"variety":[37],"approaches":[39],"to":[40,43,75,106,151],"prescribing":[41],"patients":[44,76,139,157,187,211,253,284],"based":[45],"on":[46,207,249,285,331],"individual":[48],"characteristics.":[49],"At":[50],"same":[52],"time,":[53],"biological":[54,163,217,259],"small":[57,166,220,262],"targeted":[58,167,221,263],"molecule":[59,168,222,264],"are":[61],"characterized":[62,277],"by":[63,80,225,278],"relatively":[64],"high":[65],"costs,":[66],"primary":[69],"mechanism":[70],"ensuring":[72],"accessibility":[74],"is":[77,149,276],"reimbursement,":[78],"funded":[79],"both":[81,289],"federal":[82],"regional":[84,133,153,172,336],"budgets.":[85],"Organizing":[86],"reimbursement":[87],"implies":[88],"formalizing":[89],"selection":[91],"nomenclature":[94,109],"volumes":[96],"used.":[99],"Regional":[100],"executive":[101],"authorities":[102],"have":[103],"authority":[105],"determine":[107,132],"volume":[111],"drugs":[113],"outpatient":[115],"subsidized":[116],"medicine":[117,184,287,332],"provision,":[118],"senior":[120],"external":[121],"specialists":[122],"play":[123],"key":[125],"role":[126],"in":[127,135,180,234],"these":[128,171],"processes.":[129],"This":[130],"may":[131],"differences":[134,173],"distribution":[137,209,251],"PsA":[141,159,189,213,255,290,311,339],"AS":[143,161,215,257,292,313,343],"between":[144,162,216,258],"alternative":[145],"drugs.":[146],"Therefore,":[147],"it":[148],"important":[150],"study":[152],"practices":[154],"distributing":[156],"medicines":[164,218,265],"medicines,":[169,223],"identifying":[170],"as":[174],"basis":[176],"further":[178],"improvements":[179],"organization":[182],"provision":[185],"AS.":[191],"Using":[192],"developed":[194],"form,":[195],"data":[196,240],"were":[197,344],"collected":[198],"from":[199,241],"11":[200,242,295,316,348],"constituent":[201,243,296,317,349],"entities":[202,244,297,318,350],"Russian":[205,247,300,321,353],"Federation":[206,248,322],"followed":[224],"calculation":[226],"average":[229,281,303],"cost":[230,305],"this":[232,286],"pharmacotherapy":[233],"each":[235],"region.":[236],"An":[237],"analysis":[238],"revealed":[266],"highest":[268,280],"demand":[269],"IL-17":[272],"inhibitor":[273],"secukinumab,":[274],"which":[275],"proportion":[282],"across":[293,314,346],"all":[294,315],"Federation.":[301,354],"annual":[304],"treating":[307],"one":[308],"patient":[309],"was":[323],"554,690":[324],"rubles":[325],"542,114":[327],"rubles,":[328],"respectively.":[329],"Based":[330],"consumption":[333],"patterns,":[334],"five":[335],"groups":[337],"two":[341],"formed":[345]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-01-20T00:00:00"}